Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

St Jude's "thinnest" implantable cardioverter defibrillator lead:

This article was originally published in Clinica

Executive Summary

St Jude Medical has received US FDA approval to sell what it claims is the world's thinnest implantable cardioverter defibrillator (ICD) lead. The Riata ST 6.3F lead has an "ultra-thin diameter", making it easier for doctors to handle the device and to position it precisely at the cardiac site, said the St Paul, Minnesota firm. It preserves venous space, an important consideration when treating patients with implantable devices, especially those with pre-existing or multiple lead systems, as it minimises restriction to blood flow. Riata ST is thinner than previous versions of St Jude's Riata ICD lead family.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT051529

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel